The largest database of trusted experimental protocols

Firefly luciferase assay kit 2

Manufactured by Biotium
Sourced in United States

The Firefly Luciferase Assay Kit 2.0 is a reagent system designed to measure the activity of firefly luciferase, a commonly used reporter enzyme. The kit provides the necessary components to quantify luciferase activity in cell lysates or purified protein samples.

Automatically generated - may contain errors

10 protocols using firefly luciferase assay kit 2

1

Quantifying Antiviral Activity of Ser4 Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the antiviral activity of Ser4 and its mutants, viruses were produced from 293T cells after transfection with 1 μg pH-22, pH22ΔN, pHAD8, Ph-AD8ΔN together with various amounts of Ser4 expression vectors using polyethylenimine (PEI). Forty-eight hours later, the culture supernatants were collected, and the virus titer in which was quantified by p24Gag ELISA as reported (Wehrly and Chesebro, 1997 (link)). To determine viral infectivity, equal amounts of viruses as normalized to the levels of p24Gag were used to infect the HIV-1 luciferase reporter cell line TZM-bI in a 96-well plate at a density of 1 × 104 per well. After 48 h, cells were lysed and intracellular luciferase activities were determined using Firefly Luciferase Assay Kit 2.0 (Biotium). These luciferase activities were used to calculate viral infectivity.
+ Open protocol
+ Expand
2

Screening of JAK/STAT Inhibitors Against CSFV

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PEDSV.15 cells seeded in 96-well plates (3 × 104 cells/100 µL/well) were treated with small-molecule compounds of the JAK/STAT Compound Library (Targetmol, Wellesley Hills, MA, USA, cat. No. L3700) at two concentrations (0.5 µM and 5 µM) for approximately one hour prior to stimulation with either LPS (100 ng/mL), pTNF (5 ng/mL) or the medium. After a stimulation period of six hours, the cells were infected with CSFV-luc at a multiplicity of infection (MOI) of 0.1 TCID50/cell, and after 22 h of cultivation, the cell extracts were assayed for firefly luciferase activity (Firefly Luciferase Assay Kit 2.0, Biotium, Fremont, CA, USA) using a Centro LB 960 luminometer (Berthold Technologies, Bad Wildbad, Germany). Average relative luminescence units (RLU) with standard deviations from triplicate values were calculated. The data obtained from cytotoxic or antiviral compounds were eliminated from the analysis (RLU below 50% of non-stimulated infected cultures).
+ Open protocol
+ Expand
3

Measurement of CSFV Replicon Luciferase Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the measurement of CSFV replicon-mediated firefly luciferase activity, 3 × 106 PEDVS.15 cells were electroporated with 1 μg of replicon T7-RNA in 0.4 mL of ice-cold phosphate-buffered saline (PBS). Electroporations were performed using an ECM® 830 electroporator (BTX, Holliston, MA, USA) with the following settings: 980V and two pulses of 100 µs pulse length at a 0.1 s interval. After 16 and 24 h, the cells were lysed through the addition of 1× Firefly Luciferase Lysis Buffer (Biotium, Fremont, CA, USA), and cell extracts were assayed for firefly luciferase activity (Firefly Luciferase Assay Kit 2.0, Biotium) using white 96-well microplates (Lumitrac, Greiner Bio-One, Kremsmünster, Austria) and a GloMax® plate reader (Promega, Madison, WI, USA). To normalize firefly luciferase activity to the efficiency of replicon T7-RNA transfection, replica cultures of electroporated PEDSV.15 cells were subjected to E2 immunostaining and flow cytometry quantification.
+ Open protocol
+ Expand
4

Bioluminescence Assay for P. berghei

Check if the same lab product or an alternative is used in the 5 most similar protocols
The P. berghei ANKA parasite strain used in this study expresses luciferase. Based on this, parasite load was determined using the Firefly Luciferase Assay Kit 2.0 (Biotium). One microliter of blood was collected from the tail tip once a day starting day 4 post-infection. Blood was centrifuged and red blood cells were lysed using Lysis buffer 1x. For parasite organ sequestration, on day 7 post-infection, animals were euthanized by cervical dislocation and intracardially perfused with PBS 1x for 3 minutes. The liver, spleen, brain, and lungs were removed and mechanically processed in Lysis buffer 1x. Bioluminescence in the red blood cell extracts or in organ supernatants was measured using an Orion II Microplate Luminometer.
+ Open protocol
+ Expand
5

Measuring miR-4417 Effect on PSMG3-AS1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pGL3-PSMG3-AS1 luciferase reporter vector (Promega Corporation) was established. Cells were transfected with miR-4417 mimic + pGL3-PSMG3-AS1 (miR-4417 group) or NC miRNA + pGL3-PSMG3-AS1 (NC miRNA group) using the aforementioned transfection method. Luciferase activity was measured after 48 h using the Firefly Luciferase Assay kit 2.0 (Biotium, Inc.). Firefly luciferase activity was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand
6

Quantifying Luciferase Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dual luciferase assay reactions were prepared using Firefly Luciferase Assay Kit 2.0 (Biotium, California, USA), following manufacturer's instructions. Luciferase activity was quantified using GloMax® Discover Microplate Reader (Promega). Results are expressed as Luciferase/Renilla ratios.
+ Open protocol
+ Expand
7

Quantifying Malaria Parasite Burden

Check if the same lab product or an alternative is used in the 5 most similar protocols

P. berghei parasitemia was determined in blood collected from the mouse tail using the Firefly Luciferase Assay Kit 2.0 (Biotium, Fremont, CA, USA), according to the manufacturer’s instructions. In vivo liver infection was quantified by imaging using XenoLight D-Luciferin - Potassium Salt Bioluminescent Substrate (PerkinElmer, Waltham, MA, USA) and the IVIS Lumina Imaging System (Caliper LifeSciences, Waltham, MA, USA).
+ Open protocol
+ Expand
8

Dual-Luciferase Assay Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dual-luciferase assay reactions were prepared using the Firefly Luciferase Assay Kit 2.0 (Biotium, California, United States), following manufacturer’s instructions. Luciferase activity was quantified using GloMax® Discover Microplate Reader (Promega). Results are expressed as Luciferase/Renilla ratios.
+ Open protocol
+ Expand
9

Quantifying Antiviral Activity of Ser4 Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the antiviral activity of Ser4 and its mutants, viruses were produced from 293T cells after transfection with 1 μg pH-22, pH22ΔN, pHAD8, Ph-AD8ΔN together with various amounts of Ser4 expression vectors using polyethylenimine (PEI). Forty-eight hours later, the culture supernatants were collected, and the virus titer in which was quantified by p24Gag ELISA as reported (Wehrly and Chesebro, 1997 (link)). To determine viral infectivity, equal amounts of viruses as normalized to the levels of p24Gag were used to infect the HIV-1 luciferase reporter cell line TZM-bI in a 96-well plate at a density of 1 × 104 per well. After 48 h, cells were lysed and intracellular luciferase activities were determined using Firefly Luciferase Assay Kit 2.0 (Biotium). These luciferase activities were used to calculate viral infectivity.
+ Open protocol
+ Expand
10

In vitro Evaluation of Antimalarial Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity of compounds against P. berghei-infected Huh7 cells was assessed in vitro by bioluminescence, as previously described58 (link). Briefly, Huh7 cells were seeded as indicated above on the day prior to infection. Compound stock solutions were prepared in DMSO. Test concentrations were obtained by serial dilution of compound stock solutions in infection medium, i.e. complete culture medium supplemented with 50 µg/mL of gentamicin and 0.8 µg/mL of fungizone. After 1 h of incubation with selected compound dilutions, 1 × 104 luciferase-expressing P. berghei sporozoites were added per well. Plates were centrifuged and incubated for 46 h at 37 °C, 5% CO2. At this timepoint, the impact of the compounds on cell viability was assessed by the AlamarBlue (Invitrogen) assay, according to the manufacturer’s recommendations. Next, compounds’ impact on parasite load was assessed by bioluminescence, employing the Firefly Luciferase Assay Kit 2.0 (Biotium).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!